4.7 Article

Adipose-Derived Stem Cells Primed with Paclitaxel Inhibit Ovarian Cancer Spheroid Growth and Overcome Paclitaxel Resistance

Related references

Note: Only part of the references are listed.
Review Cell Biology

Advances in therapeutic applications of extracellular vesicles

Oscar P. B. Wiklander et al.

SCIENCE TRANSLATIONAL MEDICINE (2019)

Review Chemistry, Multidisciplinary

Systematic review of targeted extracellular vesicles for drug delivery - Considerations on methodological and biological heterogeneity

Johann Mar Gudbergsson et al.

JOURNAL OF CONTROLLED RELEASE (2019)

Article Pharmacology & Pharmacy

Engineered Mesenchymal Stem Cells for Targeting Solid Tumors: Therapeutic Potential beyond Regenerative Therapy

Shen Cheng et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2019)

Article Pharmacology & Pharmacy

The Challenges and Possibilities of Extracellular Vesicles as Therapeutic Vehicles

Genevieve E. Melling et al.

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2019)

Article Multidisciplinary Sciences

Adipocytes promote ovarian cancer chemoresistance

Jiang Yang et al.

SCIENTIFIC REPORTS (2019)

Article Oncology

Cancer statistics, 2019

Rebecca L. Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2019)

Review Cell Biology

Shedding light on the cell biology of extracellular vesicles

Guillaume van Niel et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2018)

Review Cell & Tissue Engineering

Concise Review: Mesenchymal Stem Cell-Based Drug Delivery: The Good, the Bad, the Ugly, and the Promise

Timothy E. G. Krueger et al.

STEM CELLS TRANSLATIONAL MEDICINE (2018)

Review Oncology

Advances in ovarian cancer therapy

Alexander J. Cortez et al.

CANCER CHEMOTHERAPY AND PHARMACOLOGY (2018)

Review Chemistry, Multidisciplinary

Mesenchymal stem/stromal cell extracellular vesicles: From active principle to next generation drug delivery system

Barbara Crivelli et al.

JOURNAL OF CONTROLLED RELEASE (2017)

Article Biochemistry & Molecular Biology

Anoikis resistance is a critical feature of highly aggressive ovarian cancer cells

Q. Cai et al.

ONCOGENE (2015)

Article Oncology

Preclinical Activity of the Liposomal Cisplatin Lipoplatin in Ovarian Cancer

Naike Casagrande et al.

CLINICAL CANCER RESEARCH (2014)

Article Immunology

ADIPOSE TISSUE-DERIVED STROMAL CELLS PRIMED IN VITRO WITH PACLITAXEL ACQUIRE ANTI-TUMOR ACTIVITY

A. Bonomi et al.

INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2013)

Article Medicine, Research & Experimental

A three-dimensional microenvironment alters protein expression and chemosensitivity of epithelial ovarian cancer cells in vitro

Janet Myungjin Lee et al.

LABORATORY INVESTIGATION (2013)

Review Oncology

Latest research and treatment of advanced-stage epithelial ovarian cancer

Robert L. Coleman et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2013)

Article Medical Laboratory Technology

High-throughput plasma docetaxel quantification by liquid chromatography-tandem mass spectrometry

Giuseppe Corona et al.

CLINICA CHIMICA ACTA (2011)

Article Multidisciplinary Sciences

Mesenchymal Stromal Cells Primed with Paclitaxel Provide a New Approach for Cancer Therapy

Augusto Pessina et al.

PLOS ONE (2011)

Article Oncology

Paclitaxel Resistance: Molecular Mechanisms and Pharmacologic Manipulation

R. Z. Yusuf et al.

CURRENT CANCER DRUG TARGETS (2003)